Related Experiment Video
Updated: May 9, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
[Role of autophagy on cobrotoxin induced cell death of A549]
Jian Shen1, Jingkang He, Xing Tang
1The First Affiliated Hospital of Suzhou University, Suzhou 215000, China.
Background:
It has been proven that cobrotoxin has anti-tumor effect while its role in lung cancer is rarely studied. The aim of this study is to assay the anti-tumor effect of cobrotoxin in cell line A549, and also to explore its possible mechanism related to autophagy and P38-MARK pathway.
Methods:
Using MTT method to observe the inhibition effect of cobrotoxin on the growth of adenocarcinoma cell A549 and human lung fibroblast cell HFL1, as well as on that of A549 pretreated with 3-MA and SB203580, which are the inhibitor of autophagy and P38-MARK pathway respectively. Cell colony tablet cloning experiment was executed to detect the effect of cobrotoxin on colony formation of A549. Determining the protein levels of beclin-1, LC3, p38 and pP38 in A549 by Western blot after cells were exposed to cobrotoxin, or to cobrotoxin combined with either 3-MA or SB203580.
Results:
All of different concentrations of cobrotoxin inhibited the growth of A549, but had no obvious effect on that of HFL1. After treating with 3-MA or SB203580, the suppress effect of cobrotoxin on A549 reduced. What's more, different concentrations of cobrotoxin all significantly suppressed the colony formation of A549. The expression of beclin-1 and pP38 in A549 increased obviously after exposure to cobrotoxin, and also the ratio of LC3 II to LC3 I amplified with a dose-dependant manner, but P62 decreased. The protein level of beclin-1 and the ratio of LC3 II to LC3 I in cells pretreated with 3-MA were reduced, while that of p62 was increased. Also, in cells that treated with SB203580 before exposed to cobrotoxin, the expression of beclin-1, pP38 and the ratio of of LC3 II to LC3 I were reduced, but the expression of P62 increased.
Conclusions:
Cobrotoxin can suppress the growth of A549 in vitro. And the activating of P38-MARK pathway, then upregulating autophagy, was involved in cobrotoxin induced anti-tumor process.
Insights
Cobrotoxin effectively inhibits lung cancer cell growth by activating the P38-MAPK pathway and promoting autophagy. This study reveals cobrotoxin
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Cobrotoxin exhibits anti-tumor properties, but its specific role in lung cancer remains under-investigated.
- Lung adenocarcinoma cell line A549 is a relevant model for studying anti-cancer agents.
Purpose of the Study:
- To evaluate the anti-tumor effects of cobrotoxin on A549 lung cancer cells.
- To elucidate the underlying mechanisms involving autophagy and the P38-MAPK pathway.
Main Methods:
- Cell viability was assessed using the MTT assay.
- Colony formation assays evaluated the long-term effects of cobrotoxin.
- Western blotting was employed to analyze protein expression levels of key autophagy and signaling pathway markers.
Main Results:
- Cobrotoxin significantly inhibited A549 cell proliferation and colony formation in a dose-dependent manner.
- Cobrotoxin treatment led to increased expression of beclin-1, pP38, and the LC3 II/LC3 I ratio, indicating autophagy activation.
- Inhibition of autophagy or the P38-MAPK pathway attenuated the anti-tumor effects of cobrotoxin.
Conclusions:
- Cobrotoxin demonstrates significant in vitro anti-tumor activity against A549 lung cancer cells.
- The anti-tumor mechanism involves the activation of the P38-MAPK pathway, which subsequently upregulates autophagy.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

